Greenville Health System Cancer Institute-Seneca — Seneca, South Carolina

Greenville Health System Cancer Institute-Seneca is a clinical research site located in Seneca, South Carolina, United States 29672.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

Greenville Health System Cancer Institute-Seneca has participated in 67 clinical trials with 9 currently active.

Therapeutic areas: Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome.

Sponsors: Alliance for Clinical Trials in Oncology, Gynecologic Oncology Group, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seneca

Browse all research sites in South Carolina · View every site in Seneca

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenville Health System Cancer Institute-Seneca?

Greenville Health System Cancer Institute-Seneca has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenville Health System Cancer Institute-Seneca conducted?

Greenville Health System Cancer Institute-Seneca has 67 clinical trials on record, with 9 currently active. Their work covers Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome.

Is Greenville Health System Cancer Institute-Seneca accredited by Crixeo Clinical Trials?

Greenville Health System Cancer Institute-Seneca has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenville Health System Cancer Institute-Seneca?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.